Christine T Ferrara1, Susan M Geyer2, Carmella Evans-Molina3, Ingrid M Libman4, Dorothy J Becker4, John M Wentworth5, Antoinette Moran6, Stephen E Gitelman1, Maria J Redondo7. 1. Department of Pediatric Endocrinology, University of California at San Francisco94143. 2. Department of Informatics and Biostatistics, University of Southern Florida. 3. Department of Medicine, Indiana University School of Medicine. 4. Department of Pediatric Endocrinology, Children's Hospital of Pittsburgh of UPMC. 5. Department of Medicine, Royal Melbourne Hospital, Australia. 6. Department of Pediatric Endocrinology, University of Minnesota. 7. Section of Pediatric Endocrinology, Texas Children's Hospital.
Abstract
Background: Given the global rise in both type 1 diabetes incidence and obesity, the role of body mass index (BMI) on type 1 diabetes pathophysiology has gained great interest. Sustained excess BMI in pediatric participants of the TrialNet Pathway to Prevention (PTP) cohort increased risk for progression to type 1 diabetes, but the effects of age and obesity in adults remain largely unknown. Objective: To determine the effect of age and sustained obesity on the risk for type 1 diabetes in adult participants in the TrialNet PTP cohort (i.e., nondiabetic autoantibody-positive relatives of patients with type 1 diabetes). Research Design and Methods: Longitudinally accumulated BMI >25 kg/m2 was calculated to generate a cumulative excess BMI (ceBMI) for each participant, with ceBMI values ≥0 kg/m2 and ≥5 kg/m2 representing sustained overweight or obese status, respectively. Recursive partitioning analysis yielded sex- and age-specific thresholds for ceBMI that confer the greatest risk for type 1 diabetes progression. Results: In this cohort of 665 adults (age 20 to 50 years; median follow-up, 3.9 years), 49 participants developed type 1 diabetes. Age was an independent protective factor for type 1 diabetes progression (hazard ratio, 0.95; P = 0.008), with a threshold of >35 years that reduced risk for type 1 diabetes. In men age >35 years and women age <35 years, sustained obesity (ceBMI ≥5 kg/m2) increased the risk for type 1 diabetes. Conclusions: Age is an important factor for type 1 diabetes progression in adults and influences the impact of elevated BMI, indicating an interplay of excess weight, age, and sex in adult type 1 diabetes pathophysiology.
Background: Given the global rise in both type 1 diabetes incidence and obesity, the role of body mass index (BMI) on type 1 diabetes pathophysiology has gained great interest. Sustained excess BMI in pediatric participants of the TrialNet Pathway to Prevention (PTP) cohort increased risk for progression to type 1 diabetes, but the effects of age and obesity in adults remain largely unknown. Objective: To determine the effect of age and sustained obesity on the risk for type 1 diabetes in adult participants in the TrialNet PTP cohort (i.e., nondiabetic autoantibody-positive relatives of patients with type 1 diabetes). Research Design and Methods: Longitudinally accumulated BMI >25 kg/m2 was calculated to generate a cumulative excess BMI (ceBMI) for each participant, with ceBMI values ≥0 kg/m2 and ≥5 kg/m2 representing sustained overweight or obese status, respectively. Recursive partitioning analysis yielded sex- and age-specific thresholds for ceBMI that confer the greatest risk for type 1 diabetes progression. Results: In this cohort of 665 adults (age 20 to 50 years; median follow-up, 3.9 years), 49 participants developed type 1 diabetes. Age was an independent protective factor for type 1 diabetes progression (hazard ratio, 0.95; P = 0.008), with a threshold of >35 years that reduced risk for type 1 diabetes. In men age >35 years and women age <35 years, sustained obesity (ceBMI ≥5 kg/m2) increased the risk for type 1 diabetes. Conclusions: Age is an important factor for type 1 diabetes progression in adults and influences the impact of elevated BMI, indicating an interplay of excess weight, age, and sex in adult type 1 diabetes pathophysiology.
Authors: Elizabeth J Mayer-Davis; Jean M Lawrence; Dana Dabelea; Jasmin Divers; Scott Isom; Lawrence Dolan; Giuseppina Imperatore; Barbara Linder; Santica Marcovina; David J Pettitt; Catherine Pihoker; Sharon Saydah; Lynne Wagenknecht Journal: N Engl J Med Date: 2017-04-13 Impact factor: 91.245
Authors: Jay S Skyler; Carla J Greenbaum; John M Lachin; Ellen Leschek; Lisa Rafkin-Mervis; Peter Savage; Lisa Spain Journal: Ann N Y Acad Sci Date: 2008-12 Impact factor: 5.691
Authors: Jeffrey A Johnson; Stephanie U Vermeulen; Ellen L Toth; Brenda R Hemmelgarn; Kelli Ralph-Campbell; Greg Hugel; Malcolm King; Lynden Crowshoe Journal: Can J Public Health Date: 2009 May-Jun
Authors: Niina Lammi; Paul A Blomstedt; Elena Moltchanova; Johan G Eriksson; Jaakko Tuomilehto; Marjatta Karvonen Journal: Acta Obstet Gynecol Scand Date: 2009 Impact factor: 3.636
Authors: Kendra Vehik; Craig A Beam; Jeffrey L Mahon; Desmond A Schatz; Michael J Haller; Jay M Sosenko; Jay S Skyler; Jeffrey P Krischer Journal: Diabetes Care Date: 2011-07-12 Impact factor: 19.112
Authors: Christine Ferrara-Cook; Susan Michelle Geyer; Carmella Evans-Molina; Ingrid M Libman; Dorothy J Becker; Stephen E Gitelman; Maria Jose Redondo Journal: Diabetes Care Date: 2020-01-14 Impact factor: 19.112
Authors: Stephen R Karpen; Jessica L Dunne; Brigitte I Frohnert; Marjana Marinac; Claudia Richard; Sarah E David; Inish M O'Doherty Journal: Diabetologia Date: 2022-07-22 Impact factor: 10.460
Authors: Maria J Redondo; Andrea K Steck; Jay Sosenko; Mark Anderson; Peter Antinozzi; Aaron Michels; John M Wentworth; Mark A Atkinson; Alberto Pugliese; Susan Geyer Journal: Diabetes Care Date: 2018-10-01 Impact factor: 19.112
Authors: Cate Speake; Samuel O Skinner; Dror Berel; Elizabeth Whalen; Matthew J Dufort; William Chad Young; Jared M Odegard; Anne M Pesenacker; Frans K Gorus; Eddie A James; Megan K Levings; Peter S Linsley; Eitan M Akirav; Alberto Pugliese; Martin J Hessner; Gerald T Nepom; Raphael Gottardo; S Alice Long Journal: JCI Insight Date: 2019-12-05
Authors: Maria J Redondo; Brandon M Nathan; Laura M Jacobsen; Emily Sims; Laura E Bocchino; Alberto Pugliese; Desmond A Schatz; Mark A Atkinson; Jay Skyler; Jerry Palmer; Susan Geyer; Jay M Sosenko Journal: Diabetologia Date: 2021-01-26 Impact factor: 10.122
Authors: Michelle So; Colin O'Rourke; Alyssa Ylescupidez; Henry T Bahnson; Andrea K Steck; John M Wentworth; Brittany S Bruggeman; Sandra Lord; Carla J Greenbaum; Cate Speake Journal: Diabetologia Date: 2022-01-18 Impact factor: 10.122
Authors: Maria J Redondo; Susan Geyer; Andrea K Steck; Seth Sharp; John M Wentworth; Michael N Weedon; Peter Antinozzi; Jay Sosenko; Mark Atkinson; Alberto Pugliese; Richard A Oram Journal: Diabetes Care Date: 2018-07-12 Impact factor: 19.112